915095-89-5Relevant articles and documents
Enantioselective Hydrogenation toward Chiral 3-Aryloxy Tetrahydrofurans Enabled by Spiro Ir-PNN Catalysts Containing an Unusual 5-Substituted Chiral Oxazoline Unit
Gu, Xue-Song,Xie, Jian-Hua,Xiong, Ying,Yan, Pu-Cha,Yang, Fan,Yu, Na,Zhou, Qi-Lin
, p. 2206 - 2211 (2022/02/09)
An iridium-catalyzed asymmetric hydrogenation of racemic α-aryloxy lactones involving dynamic kinetic resolution was successfully implemented by chiral spiro PNN-ligands containing a C5-substituted chiral oxazoline unit. This protocol along with simple dehydration constitutes the most straightforward approach to prepare enantiomerically enriched 3-aryloxy tetrahydrofurans, which are prevalent structural motifs in many approved drugs and clinical candidates. The hydrogenation step features high yields (90-96%), low catalyst loading (0.2-0.1 mol %), and high enantioselectivities (91-96% ee), and the dehydration step is absolutely stereospecific with high yields (up to 96%) under the mild condition. Moreover, the synthetic utility was further proved by the formal enantioselective synthesis of empagliflozin and production of 3-aryloxy pyrrolidine units.
Preparation process of empagliflozin intermediate
-
, (2021/07/17)
The invention discloses a preparation process of an empagliflozin intermediate, and relates to the technical field of biological pharmacy, the process comprises the following steps: taking a compound of a formula d structure and s-3-hydroxytetrahydrofuran (namely a compound e) as initial raw materials, dehydrating to obtain a compound of a formula c structure; sequentially adding alkali metal and a chlorination reagent to obtain a compound b; further performing Friedel-Crafts reaction with a compound with a structure as shown in a formula f under the catalytic action of Lewis acid to synthesize a compound with a structure as shown in a formula a; and finally, carrying out reduction reaction to obtain a target compound with a structure shown in a formula g. The preparation method is low in cost, easy to operate, less in wastewater, easy in post-treatment, high in yield, high in product purity and suitable for industrial production.
A NEW HETEROCYCLIC COMPOUND: CRYSTAL STRUCTURE AND ANTICANCER ACTIVITY AGAINST HUMAN LUNG ADENOCARCINOMA CELLS
Li, H.,Li, X. X.,Shen, L.,Shi, E. H.,Wang, L. R.,Zhang, C. Y.,Zhang, D. L.,Zhao, S.
, p. 1167 - 1174 (2020/09/09)
Abstract: New heterocyclic compound (S)-3-(4-(5-bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran (1), designed by utilizing 5-bromo-2-chlorobenzoic acid (2) as the starting material, is obtained by the organic synthesis and then characterized by single crystal X-ray crystallography, 1H NMR and IR spectroscopy. In the biological study, the CCK-8 assay is performed to evaluate the inhibitory effect of the compound on SPC-A-1 human lung adenocarcinoma cells in vitro by measuring the cancer cell viability. Then, the anticancer activity of the compound is also confirmed by the in vivo xenograft experiment by measuring the mice body weight and the cancer volume.